| Serial Number | 76113585 |
| Word Mark | DURASONE |
| Filing Date | Wednesday, August 16, 2000 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, May 16, 2009 |
| Registration Number | 2611636 |
| Registration Date | Tuesday, August 27, 2002 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 4, 2002 |
| Goods and Services | Describing and providing medical diagnostic and pharmaceutical preparations with anti-sense oligonucleotides for testing, preventing, and therapeutically treating human and non-human animal respiratory ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing; impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms; pharmaceutical preparations for the treatment of airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SuperaVentricular Tachycardia (STV), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc, as well as all other metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, May 16, 2009 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, December 31, 1998 |
| First Use In Commerce Date | Thursday, December 31, 1998 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Saturday, May 16, 2009 | CANCELLED SEC. 8 (6-YR) |
| Monday, October 1, 2007 | CASE FILE IN TICRS |
| Tuesday, August 27, 2002 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 4, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 15, 2002 | NOTICE OF PUBLICATION |
| Wednesday, January 30, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 27, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 22, 2001 | NON-FINAL ACTION MAILED |
| Wednesday, March 14, 2001 | ASSIGNED TO EXAMINER |
| Friday, February 16, 2001 | ASSIGNED TO EXAMINER |